The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab (Q83143549)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21211590%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21211590%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

1 reference

U Arad

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21211590%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

S Tzadok

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21211590%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

S Amir

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21211590%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

M Mandelboim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21211590%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

E Mendelson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21211590%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

I Wigler

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21211590%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

H Sarbagil-Maman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21211590%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

D Paran

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21211590%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

D Caspi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21211590%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

O Elkayam

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21211590%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

4 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21211590%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21211590%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21211590%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21211590%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

1643-1648

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21211590%20AND%20SRC:MED&resulttype=core&format=json

Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

Infections in patients with rheumatoid arthritis treated with biologic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

The risk of infections with biologic therapies for rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: An open-label extension analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

Attenuated antibody reaction for the primary antigen but not for the recall antigen of influenza vaccination in patients with non-Hodgkin B-cell lymphoma after the administration of rituximab-CHOP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

Cell-mediated protection in influenza infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

Influenza control in the 21st century: Optimizing protection of older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

T cell responses are better correlates of vaccine protection in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

Cell-mediated immune responses to influenza vaccination in Wegener's granulomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

Requirement of B cells for generating CD4+ T cell memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

A specific role for B cells in the generation of CD8 T cell memory by recombinant Listeria monocytogenes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

Cytotoxic T-cell immunity to influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

ELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

Cell-mediated immune responses to influenza vaccination in healthy volunteers and allogeneic stem cell transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

Flu vaccination with a virosomal vaccine does not affect clinical course and immunological parameters in scleroderma patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.072

10.1016/J.VACCINE.2010.12.072

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21211590%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference